16236500

Source:http://linkedlifedata.com/resource/pubmed/id/16236500

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0043309, umls-concept:C0205314, umls-concept:C0268563, umls-concept:C0678594, umls-concept:C0679622, umls-concept:C1827106, umls-concept:C1880355, umls-concept:C2917254
pubmed:issue	1
pubmed:dateCreated	2005-11-18
pubmed:abstractText	The discovery, SAR, and X-ray crystal structure of novel biarylaminoacyl-(S)-2-cyano-pyrrolidines and biarylaminoacylthiazolidines as potent inhibitors of dipeptidyl peptidase IV (DPP IV) are reported.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Dipeptidyl Peptidase 4, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protease Inhibitors
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	0960-894X
pubmed:author	pubmed-author:AbadMarta CMC, pubmed-author:BaumannChristian ACA, pubmed-author:BayoumyShariff SSS, pubmed-author:CryslerCarl SCS, pubmed-author:DasguptaMaliniM, pubmed-author:DeckmanIngrid CIC, pubmed-author:DesjarlaisRenee LRL, pubmed-author:HuebertNorman DND, pubmed-author:KervinenJukkaJ, pubmed-author:MoriartyKevin JKJ, pubmed-author:NeeperMike PMP, pubmed-author:NinanNisha SNS, pubmed-author:QiaoLeiL, pubmed-author:ReedRolanda LRL, pubmed-author:SpurlinoJohn CJC, pubmed-author:TomczukBruce EBE, pubmed-author:WilliamsRobynR
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	16
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	123-8
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:16236500-Animals, pubmed-meshheading:16236500-Antineoplastic Agents, pubmed-meshheading:16236500-Binding Sites, pubmed-meshheading:16236500-Blood Glucose, pubmed-meshheading:16236500-Caco-2 Cells, pubmed-meshheading:16236500-Chemistry, Pharmaceutical, pubmed-meshheading:16236500-Crystallography, X-Ray, pubmed-meshheading:16236500-Dipeptidyl Peptidase 4, pubmed-meshheading:16236500-Drug Design, pubmed-meshheading:16236500-Drug Screening Assays, Antitumor, pubmed-meshheading:16236500-Enzyme Inhibitors, pubmed-meshheading:16236500-Humans, pubmed-meshheading:16236500-Kinetics, pubmed-meshheading:16236500-Mice, pubmed-meshheading:16236500-Models, Chemical, pubmed-meshheading:16236500-Models, Molecular, pubmed-meshheading:16236500-Protease Inhibitors, pubmed-meshheading:16236500-Rats, pubmed-meshheading:16236500-Structure-Activity Relationship
pubmed:year	2006
pubmed:articleTitle	Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
pubmed:affiliation	Johnson and Johnson Pharmaceutical Research and Development, 665 Stockton Drive, Exton, PA 19341, USA.
pubmed:publicationType	Journal Article